DK1282446T3 - Farmaceutisk og/eller kosmetisk præparat indeholdende en organosiloxan og et phospholipid - Google Patents

Farmaceutisk og/eller kosmetisk præparat indeholdende en organosiloxan og et phospholipid

Info

Publication number: DK1282446T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical; cosmetic composition; phospholipid; organosiloxane; composition containing
Prior art date: 2000-05-19

Application number

DK01940156T

Other languages

English (en)

Inventor

Ralf Piotrowiak

Bernd G Seigfried

Original Assignee

Mika Pharma Ges Fuer Die Entwi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-19

Filing date

2001-04-14

Publication date

2008-01-02

2001-04-14 Application filed by Mika Pharma Ges Fuer Die Entwi filed Critical Mika Pharma Ges Fuer Die Entwi

2008-01-02 Application granted granted Critical

2008-01-02 Publication of DK1282446T3 publication Critical patent/DK1282446T3/da

Links

239000002537 cosmetic Substances 0.000 title abstract 5
150000003904 phospholipids Chemical class 0.000 title abstract 2
125000005375 organosiloxane group Chemical group 0.000 title 1
241001465754 Metazoa Species 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
239000003146 anticoagulant agent Substances 0.000 abstract 2
150000003961 organosilicon compounds Chemical class 0.000 abstract 2
230000000202 analgesic effect Effects 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
230000003266 anti-allergic effect Effects 0.000 abstract 1
230000001088 anti-asthma Effects 0.000 abstract 1
230000000844 anti-bacterial effect Effects 0.000 abstract 1
230000001773 anti-convulsant effect Effects 0.000 abstract 1
230000003474 anti-emetic effect Effects 0.000 abstract 1
230000000648 anti-parkinson Effects 0.000 abstract 1
230000003356 anti-rheumatic effect Effects 0.000 abstract 1
239000000924 antiasthmatic agent Substances 0.000 abstract 1
229940127219 anticoagulant drug Drugs 0.000 abstract 1
239000001961 anticonvulsive agent Substances 0.000 abstract 1
239000002111 antiemetic agent Substances 0.000 abstract 1
229960003965 antiepileptics Drugs 0.000 abstract 1
239000000939 antiparkinson agent Substances 0.000 abstract 1
239000003435 antirheumatic agent Substances 0.000 abstract 1
229940124584 antitussives Drugs 0.000 abstract 1
239000002249 anxiolytic agent Substances 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
239000000824 cytostatic agent Substances 0.000 abstract 1
230000001085 cytostatic effect Effects 0.000 abstract 1
ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000000855 fungicidal effect Effects 0.000 abstract 1
239000000417 fungicide Substances 0.000 abstract 1
230000001553 hepatotropic effect Effects 0.000 abstract 1
230000002519 immonomodulatory effect Effects 0.000 abstract 1
230000001506 immunosuppresive effect Effects 0.000 abstract 1
230000000926 neurological effect Effects 0.000 abstract 1
230000002537 thrombolytic effect Effects 0.000 abstract 1
239000012873 virucide Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Birds (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Fertilizers (AREA)

DK01940156T 2000-05-19 2001-04-14 Farmaceutisk og/eller kosmetisk præparat indeholdende en organosiloxan og et phospholipid DK1282446T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10024413A DE10024413A1 (de)	2000-05-19	2000-05-19	Pharmazeutische und/oder kosmetische Zubereitung
PCT/DE2001/001483 WO2001087344A1 (de)	2000-05-19	2001-04-14	Pharmazeutische und/oder kosmetische zubereitung enthaltend ein organosiloxan und ein phospholipid

Publications (1)

Publication Number	Publication Date
DK1282446T3 true DK1282446T3 (da)	2008-01-02

Family

ID=7642554

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK01940156T DK1282446T3 (da)	2000-05-19	2001-04-14	Farmaceutisk og/eller kosmetisk præparat indeholdende en organosiloxan og et phospholipid
DK07004211.4T DK1818041T3 (da)	2000-05-19	2001-04-14	Farmaceutisk og/eller kosmetisk præparat indeholdende en organosiloxan og et phospholipid

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK07004211.4T DK1818041T3 (da)	2000-05-19	2001-04-14	Farmaceutisk og/eller kosmetisk præparat indeholdende en organosiloxan og et phospholipid

Country Status (12)

Country	Link
US (1)	US20030170194A1 (da)
EP (2)	EP1282446B1 (da)
JP (1)	JP2003533491A (da)
AT (2)	ATE380036T1 (da)
AU (1)	AU2001273839A1 (da)
CY (2)	CY1107159T1 (da)
DE (3)	DE10024413A1 (da)
DK (2)	DK1282446T3 (da)
ES (2)	ES2296758T3 (da)
PT (2)	PT1818041E (da)
SI (1)	SI1282446T1 (da)
WO (1)	WO2001087344A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10251963A1 (de) *	2002-11-08	2004-05-19	Lts Lohmann Therapie-Systeme Ag	Transmucosale pharmazeutische Darreichungsform
FR2856301B1 (fr) *	2003-06-23	2007-08-03	Galderma Res & Dev	Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
FR2867682B1 (fr) *	2004-03-22	2009-06-05	Galderma Res & Dev	Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
FR2871695B1 (fr)	2004-06-17	2008-07-04	Galderma Sa	Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
JP2008502647A (ja) *	2004-06-17	2008-01-31	ガルデルマ・ソシエテ・アノニム	シリコーン剤、コルチコステロイドおよびビタミンｄまたはその誘導体を含む乾癬治療用組成物
FR2871697B1 (fr) *	2004-06-17	2007-06-29	Galderma Sa	Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
CA2567684A1 (en) *	2004-06-17	2005-12-29	Galderma S.A.	Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
FR2871700B1 (fr) *	2004-06-17	2006-11-17	Galderma Sa	Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
US20070036731A1 (en) *	2005-08-13	2007-02-15	Collegium Pharmaceutical, Inc.	Topical Delivery with a Carrier Fluid
JP5371235B2 (ja) *	2006-12-06	2013-12-18	ロート製薬株式会社	皮膚外用剤
EP1972324A1 (en) *	2007-03-21	2008-09-24	Cognis IP Management GmbH	Encapsulated liposomes
WO2009084041A2 (en) *	2008-01-01	2009-07-09	Shasun Chemicals And Drugs Limited	Pharmaceutical compositions of dexibuprofen
IL191123A0 (en) *	2008-04-28	2009-02-11	Meir Shinitzky	Composition comprising phospholipids in combination with ascorbic acid and cosmetic products comprising it
EP2387391B1 (de)	2009-07-24	2017-01-11	MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH	Verfahren zur entwicklung einer als schaum auf die haut zu applizierenden flüssigen zusammensetzung sowie eine topisch applizierbare zusammensetzung
US20120213843A1 (en) *	2009-11-03	2012-08-23	Lipidor Ab	Composition for promoting wound healing
PT2496263T (pt) *	2009-11-03	2022-03-28	Lipidor Ab	Composição que forma uma camada lipídica para administração sobre uma superfície de um organismo vivo
US10045996B2 (en)	2010-03-17	2018-08-14	Novaliq Gmbh	Pharmaceutical composition for treatment of increased intraocular pressure
EP2444063A1 (en)	2010-10-20	2012-04-25	Novaliq GmbH	Liquid pharmaceutical compositions for the delivery of active ingredients
WO2012150890A1 (en) *	2011-05-02	2012-11-08	Lipidor Ab	Antibacterial composition
SE1300709A1 (sv) *	2013-11-14	2015-05-15	Lipidor Ab	Komposition och metod för topikal behandling
US20140073615A1 (en) *	2011-05-02	2014-03-13	Lipidor Ab	Treatment of Psoriasis
EP2714010B1 (en) *	2011-05-25	2017-03-01	Novaliq GmbH	Topical pharmaceutical composition based on semifluorinated alkanes
BR112015005008B1 (pt)	2012-09-12	2022-04-19	Novaliq Gmbh	Composições de alcano semifluorado
CN104619314B (zh)	2012-09-12	2017-09-22	诺瓦利克有限责任公司	包含半氟化烷烃的混合物的组合物
US20160081916A1 (en) *	2013-05-03	2016-03-24	Lipidor Ab	Topical Composition and Carrier for Administration of Pharmaceutically or Cosmetically Active Ingredients
CN105848684B (zh) *	2013-11-14	2020-10-16	立普妥公司	包含磷脂酰胆碱的可喷雾的局部用载体和组合物
US10149828B2 (en)	2015-01-09	2018-12-11	Chase Pharmaceuticals Corporation	Oxybutynin transdermal therapeutic system combination
CN113662929A (zh)	2015-09-30	2021-11-19	诺瓦利克有限责任公司	用于眼部给药的半氟化化合物
CN108348777B (zh)	2015-09-30	2020-04-28	诺瓦利克有限责任公司	半氟化化合物和其组合物
USRE50060E1 (en)	2016-06-23	2024-07-30	Novaliq Gmbh	Topical administration method
ES2969758T3 (es)	2016-09-22	2024-05-22	Novaliq Gmbh	Composiciones farmacéuticas para usar en la terapia de la blefaritis
KR20190057338A (ko)	2016-09-23	2019-05-28	노바리크 게엠베하	시클로스포린을 포함하는 안과 조성물
ES2819005T3 (es)	2016-12-23	2021-04-14	Novaliq Gmbh	Composición oftálmica para el tratamiento de la enfermedad del ojo seco
EP3612228B1 (en)	2017-04-21	2023-08-23	Dermaliq Therapeutics, Inc.	Iodine compositions
US11278503B2 (en)	2017-05-12	2022-03-22	Novaliq Gmbh	Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
MX2020003534A (es)	2017-09-27	2020-07-29	Novaliq Gmbh	Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
CN111182893A (zh)	2017-10-04	2020-05-19	诺瓦利克有限责任公司	包含f6h8的眼用组合物
AU2019228119A1 (en)	2018-03-02	2020-09-10	Novaliq Gmbh	Pharmaceutical compositions comprising nebivolol
IL276888B2 (en)	2018-03-28	2024-12-01	Novaliq Gmbh	Pharmaceutical composition comprising timolol
EP3784246A1 (en)	2018-04-27	2021-03-03	Novaliq GmbH	Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
EP3856124A1 (en)	2018-09-27	2021-08-04	Novaliq GmbH	Lipid barrier repair
ES2950878T3 (es)	2018-09-27	2023-10-16	Dermaliq Therapeutics Inc	Formulación de protección solar de uso tópico
CN112823020A (zh)	2018-10-12	2021-05-18	诺瓦利克有限责任公司	用于治疗干眼病的眼用组合物
EP3923907B1 (en)	2019-02-13	2024-09-25	Novaliq GmbH	Compositions and methods for the treatment of ocular neovascularization

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH072631B2 (ja) *	1987-03-06	1995-01-18	テルモ株式会社	ゲル状組成物
US4783450A (en) *	1987-04-13	1988-11-08	Warner-Lambert Company	Use of commercial lecithin as skin penetration enhancer
JPH078333B2 (ja) *	1987-12-28	1995-02-01	有限会社野々川商事	多価アルコール中油型乳化組成物及び水中油型乳化組成物
US5489433A (en) *	1991-01-04	1996-02-06	Safe-Tee Chemical Products Company	Environmentally safe insecticide
FR2679446B1 (fr) *	1991-07-24	1993-10-29	Oreal	Procede de fabrication d'une composition cosmetique pour application sur les cheveux, composition obtenue par ce procede et procede de traitement cosmetique a l'aide de ladite composition.
JPH06135816A (ja) *	1992-10-30	1994-05-17	Earth Chem Corp Ltd	化粧用組成物
JPH0823801B2 (ja) *	1993-04-26	1996-03-06	日本電気株式会社	ディスク制御装置
FR2709131B1 (fr) *	1993-08-18	1995-11-10	Cilag Laboratoire	Dispositif de distribution d'une substance thérapeutique ou cosmétique dont le véhicule inerte est un polydiorganosiloxane volatil, et composition destinée à être utilisée dans le dispositif.
US5556280A (en) *	1994-05-31	1996-09-17	Pelak; Mark S.	Method and apparatus for appliance mounting
US6045823A (en) *	1996-09-19	2000-04-04	Dragoco Gerberding & Co. Ag	Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
DE19641259A1 (de) *	1996-10-07	1998-04-16	Kade Pharma Fab Gmbh	Arzneimittel auf Basis von Diclofenac
FR2761912B1 (fr) *	1997-04-14	1999-07-02	Capsulis	Procede destine a faire adherer un produit sur une surface
DE19804837A1 (de) *	1998-01-29	1999-08-05	Coty Bv	Kosmetisches Produkt zur Regenerierung und Stimulierung der Hautzellen
FR2777179A1 (fr) *	1998-04-09	1999-10-15	Lvmh Rech	Compositions cosmetiques ou dermatologiques comprenant un vehicule a base d'un liquide hydrophobe
FR2777181A1 (fr) *	1998-04-10	1999-10-15	Lvmh Rech	Compositions cosmetiques ou dermatologiques sous forme d'emulsions de type eau-dans-huile renfermant des cyclomethicones et des phospholipides et leur procede de preparation
BE1011899A6 (fr) *	1998-04-30	2000-02-01	Ucb Sa	Compositions pharmaceutiques gelifiables utilisables.
DE19826503A1 (de) *	1998-06-13	1999-12-16	Beiersdorf Ag	Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Chitosan und Phospholipiden
IT1313595B1 (it) *	1999-08-03	2002-09-09	Giorgio Panin	Dispositivo per erogazione spray di una composizione per applicazionetopica comprendente vitamina e e acidi grassi essenziali.

2000
- 2000-05-19 DE DE10024413A patent/DE10024413A1/de not_active Ceased
2001
- 2001-04-14 WO PCT/DE2001/001483 patent/WO2001087344A1/de not_active Ceased
- 2001-04-14 DE DE50113348T patent/DE50113348D1/de not_active Expired - Lifetime
- 2001-04-14 DK DK01940156T patent/DK1282446T3/da active
- 2001-04-14 DK DK07004211.4T patent/DK1818041T3/da active
- 2001-04-14 ES ES01940156T patent/ES2296758T3/es not_active Expired - Lifetime
- 2001-04-14 AT AT01940156T patent/ATE380036T1/de active
- 2001-04-14 EP EP01940156A patent/EP1282446B1/de not_active Expired - Lifetime
- 2001-04-14 PT PT07004211T patent/PT1818041E/pt unknown
- 2001-04-14 PT PT01940156T patent/PT1282446E/pt unknown
- 2001-04-14 DE DE50115705T patent/DE50115705D1/de not_active Expired - Lifetime
- 2001-04-14 US US10/276,766 patent/US20030170194A1/en not_active Abandoned
- 2001-04-14 AT AT07004211T patent/ATE487495T1/de active
- 2001-04-14 SI SI200130802T patent/SI1282446T1/sl unknown
- 2001-04-14 JP JP2001583811A patent/JP2003533491A/ja active Pending
- 2001-04-14 AU AU2001273839A patent/AU2001273839A1/en not_active Abandoned
- 2001-04-14 ES ES07004211T patent/ES2352222T3/es not_active Expired - Lifetime
- 2001-04-14 EP EP07004211A patent/EP1818041B1/de not_active Expired - Lifetime
2008
- 2008-01-28 CY CY20081100100T patent/CY1107159T1/el unknown
2011
- 2011-02-07 CY CY20111100138T patent/CY1111533T1/el unknown

Also Published As

Publication number	Publication date
EP1818041B1 (de)	2010-11-10
DE50115705D1 (de)	2010-12-23
US20030170194A1 (en)	2003-09-11
DK1818041T3 (da)	2011-02-28
WO2001087344A1 (de)	2001-11-22
DE50113348D1 (de)	2008-01-17
PT1818041E (pt)	2010-12-28
EP1818041A3 (de)	2007-09-19
DE10024413A1 (de)	2001-12-06
EP1282446A1 (de)	2003-02-12
PT1282446E (pt)	2007-12-21
CY1111533T1 (el)	2015-08-05
CY1107159T1 (el)	2012-10-24
EP1282446B1 (de)	2007-12-05
ES2296758T3 (es)	2008-05-01
ATE487495T1 (de)	2010-11-15
AU2001273839A1 (en)	2001-11-26
EP1818041A2 (de)	2007-08-15
ATE380036T1 (de)	2007-12-15
ES2352222T3 (es)	2011-02-16
SI1282446T1 (sl)	2008-04-30
JP2003533491A (ja)	2003-11-11

Publication	Publication Date	Title
DK1818041T3 (da)	2011-02-28	Farmaceutisk og/eller kosmetisk præparat indeholdende en organosiloxan og et phospholipid
DE69530926D1 (de)	2003-07-03	Mittel zur förderung des haarwachstums
BG94837A (bg)	1993-12-24	О-метилни производни на азитромицин а, метод за тяхното получаване и приложението им като фармацевтични препарати
PT806941E (pt)	2003-08-29	Composicoes anti-bacterianas liposomicas de rigidez baixa
NO20101190L (no)	1999-10-22	Anvendelse av buprenorfin i fremstillingen av et medikament
IT1318430B1 (it)	2003-08-25	Dispositivo per l'umidificazione passiva di pazienti tracheostomizzati o intubati.
DE69630946D1 (de)	2004-01-15	Modulares system zur patientenpflege
ES2127556T3 (es)	1999-04-16	Cuerpo de moldeo implantable para la administracion de sustancias activas a plantas.
SE9601243D0 (sv)	1996-03-29	Promotion of regeneration of organized tissues
DE69616340D1 (de)	2001-11-29	Fungizide mischungen
ES2178761T3 (es)	2003-01-01	Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
NZ510153A (en)	2002-12-20	Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
ATE99669T1 (de)	1994-01-15	N-2,3-butadienyl-tri-aminoalkanderivate.
FI972004L (fi)	1997-05-12	Implantoitava laite vaikuttavien aineiden antamiseen kasveille
BG105779A (bg)	2002-04-30	Човешки антибиотични протеини
DK1156829T3 (da)	2007-09-10	Stabil formulering indeholdende fumagillin
NO307126B1 (no)	2000-02-14	Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
NO304518B1 (no)	1999-01-04	Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem
DK0659341T3 (da)	2000-01-03	Fast insecticidt præparat
BR0112369A (pt)	2003-05-13	Anti-helmìnticos para evitar infecções parasitárias no homem e animal ii
BR0112195A (pt)	2003-07-01	Anti-helmìnticos para evitar infecções parasitárias no homem e animal iii
ES1032126Y (es)	1996-09-01	Juego esterilizable para la autoinyeccion de drogas.
TR199701286T1 (xx)	1998-02-21	Karbapenemlerin esterleri.
RU96114929A (ru)	1998-10-27	Средство для лечения инфекционных заболеваний дыхательных путей
ES2162992T3 (es)	2002-01-16	Uso de 3-alfa-hidroxi-5-alfa-androsta-16-eno como medicamento.